Last checked at 20 Apr 2020 14:21
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. |
Company dealt in | ALLERGAN PLC |
Class of relevant security to which the dealings being disclosed relate (Note 2) | ORD |
Date of dealing | 17 April 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
4,336,026 | 1.32% | 3,061,696 | 0.93% | ||
(2) | Derivatives (other than options): | ||||
2,887,345 | 0.88% | 3,262,746 | 0.99% | ||
(3) | Options and agreements to | ||||
| purchase/sell: | 227,000 | 0.07% | 158,700 | 0.05% | |
| TOTAL: | |||||
7,450,371 | 2.26% | 6,483,142 | 1.97% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
3. DEALINGS (Note 4)
| (a) | Purchases and sales | |
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 1 | 186.9700 USD |
| Purchase | 1 | 186.9200 USD |
| Purchase | 3 | 187.3900 USD |
| Purchase | 53 | 186.8900 USD |
| Purchase | 150 | 186.4366 USD |
| Purchase | 152 | 186.6038 USD |
| Purchase | 200 | 187.3350 USD |
| Purchase | 200 | 186.8500 USD |
| Purchase | 200 | 187.0650 USD |
| Purchase | 200 | 187.1950 USD |
| Purchase | 243 | 186.5434 USD |
| Purchase | 300 | 186.9783 USD |
| Purchase | 400 | 187.4000 USD |
| Purchase | 400 | 187.3200 USD |
| Purchase | 825 | 186.5980 USD |
| Purchase | 1,021 | 187.2282 USD |
| Purchase | 1,200 | 186.4820 USD |
| Purchase | 1,200 | 186.7783 USD |
| Purchase | 1,645 | 186.7160 USD |
| Purchase | 2,663 | 186.4433 USD |
| Purchase | 2,790 | 186.6278 USD |
| Purchase | 3,018 | 186.5201 USD |
| Purchase | 3,159 | 186.4145 USD |
| Purchase | 3,735 | 186.6064 USD |
| Purchase | 4,591 | 186.9838 USD |
| Purchase | 4,645 | 186.5831 USD |
| Purchase | 5,173 | 186.6521 USD |
| Purchase | 5,268 | 186.4922 USD |
| Purchase | 6,220 | 186.5416 USD |
| Purchase | 7,405 | 186.6367 USD |
| Purchase | 7,442 | 186.5527 USD |
| Purchase | 7,447 | 186.6202 USD |
| Purchase | 7,509 | 186.9582 USD |
| Purchase | 10,400 | 186.4089 USD |
| Purchase | 11,790 | 186.5034 USD |
| Purchase | 16,339 | 187.0000 USD |
| Purchase | 19,672 | 186.9997 USD |
| Purchase | 20,742 | 186.8385 USD |
| Purchase | 21,024 | 186.5822 USD |
| Purchase | 25,913 | 186.8952 USD |
| Purchase | 29,817 | 186.9313 USD |
| Purchase | 30,500 | 186.9535 USD |
| Purchase | 39,600 | 186.8262 USD |
| Purchase | 115,459 | 186.9292 USD |
| Sale | 1 | 186.9200 USD |
| Sale | 3 | 187.3900 USD |
| Sale | 5 | 185.9900 USD |
| Sale | 22 | 186.6600 USD |
| Sale | 43 | 186.9900 USD |
| Sale | 100 | 186.3850 USD |
| Sale | 100 | 186.5100 USD |
| Sale | 200 | 187.0589 USD |
| Sale | 243 | 186.5434 USD |
| Sale | 300 | 186.7466 USD |
| Sale | 400 | 186.6775 USD |
| Sale | 1,300 | 186.5069 USD |
| Sale | 1,400 | 187.1192 USD |
| Sale | 1,500 | 186.9853 USD |
| Sale | 1,534 | 186.5532 USD |
| Sale | 4,806 | 187.0302 USD |
| Sale | 6,568 | 186.5879 USD |
| Sale | 12,175 | 186.6043 USD |
| Sale | 15,000 | 186.5570 USD |
| Sale | 25,800 | 186.9667 USD |
| Sale | 29,000 | 186.9519 USD |
| Sale | 37,143 | 187.0000 USD |
| Sale | 107,524 | 186.8401 USD |
| Sale | 176,191 | 186.7861 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
| Product Name | Writing, | Number | Exercise | Type | Expiry | Option |
| purchasing, | of | price | date | money | ||
| selling, | securities | paid/ | ||||
| varying etc | to which | received | ||||
| option | ||||||
| relates | ||||||
| Call Option | Selling | 1,300 | 170 USD | American | 15 May 2020 | 20.6000 USD |
| Call Option | Selling | 200 | 190 USD | American | 15 Jan 2021 | 8.6250 USD |
| Call Option | Selling | 100 | 195 USD | American | 15 Jan 2021 | 6.3500 USD |
| Put Option | Selling | 500 | 145 USD | American | 15 May 2020 | 0.9000 USD |
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 attached? (Note 9) YES
Date of disclosure | 20 April 2020 |
Contact name | Large Holdings Regulatory Operations |
Telephone number | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected |
|
If a connected EFM, state nature of connection (Note 10) |
|
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price | date | ||
| to which the option | |||||
| or derivative | |||||
| relates | |||||
| Call Options | Purchased | 6,400 | 185.0000 | American | Jan 15, 2021 |
| Put Options | Written | 200 | 190.0000 | American | Aug 21, 2020 |
| Call Options | Purchased | 600 | 175.0000 | American | Jan 15, 2021 |
| Put Options | Purchased | -100 | 140.0000 | American | May 15, 2020 |
| Call Options | Written | -1,400 | 230.0000 | American | Jun 19, 2020 |
| Put Options | Purchased | -4,500 | 70.0000 | American | Jan 15, 2021 |
| Call Options | Written | -1,500 | 220.0000 | American | Aug 21, 2020 |
| Call Options | Purchased | 6,400 | 175.0000 | American | May 15, 2020 |
| Put Options | Written | 8,200 | 150.0000 | American | May 15, 2020 |
| Put Options | Written | 43,900 | 105.0000 | American | Jan 15, 2021 |
| Put Options | Purchased | -1,200 | 65.0000 | American | Jan 15, 2021 |
| Call Options | Written | -42,500 | 165.0000 | American | Jan 21, 2022 |
| Put Options | Purchased | -16,700 | 115.0000 | American | Jan 15, 2021 |
| Call Options | Written | -3,300 | 200.0000 | American | Aug 21, 2020 |
| Call Options | Purchased | 9,500 | 170.0000 | American | Jun 19, 2020 |
| Call Options | Purchased | 32,500 | 175.0000 | American | Jan 21, 2022 |
| Call Options | Purchased | 500 | 165.0000 | American | Jan 15, 2021 |
| Call Options | Purchased | 2,100 | 190.0000 | American | May 15, 2020 |
| Put Options | Purchased | -1,100 | 195.0000 | American | May 15, 2020 |
| Put Options | Purchased | -1,400 | 165.0000 | American | May 15, 2020 |
| Put Options | Purchased | -5,200 | 170.0000 | American | Jan 15, 2021 |
| Put Options | Written | 34,800 | 140.0000 | American | Jun 19, 2020 |
| Call Options | Purchased | 1,700 | 170.0000 | American | May 15, 2020 |
| Put Options | Written | 600 | 170.0000 | American | May 15, 2020 |
| Put Options | Purchased | -6,400 | 170.0000 | American | Jun 19, 2020 |
| Put Options | Purchased | -2,000 | 190.0000 | American | May 15, 2020 |
| Put Options | Purchased | -2,600 | 75.0000 | American | Jan 15, 2021 |
| Put Options | Purchased | -3,200 | 175.0000 | American | May 15, 2020 |
| Put Options | Written | 300 | 190.0000 | American | Jun 19, 2020 |
| Put Options | Written | 14,800 | 165.0000 | American | Apr 17, 2020 |
| Put Options | Written | 6,700 | 140.0000 | American | Jan 15, 2021 |
| Call Options | Purchased | 4,500 | 190.0000 | American | Jan 15, 2021 |
| Call Options | Written | -7,200 | 260.0000 | American | Jan 15, 2021 |
| Put Options | Purchased | -38,300 | 150.0000 | American | Jan 15, 2021 |
| Call Options | Purchased | 3,400 | 160.0000 | American | Jan 15, 2021 |
| Put Options | Written | 1,300 | 195.0000 | American | Jun 19, 2020 |
| Put Options | Written | 2,800 | 180.0000 | American | May 15, 2020 |
| Put Options | Purchased | -1,100 | 185.0000 | American | Jan 15, 2021 |
| Put Options | Purchased | -1,400 | 150.0000 | American | Jun 19, 2020 |
| Put Options | Purchased | -3,200 | 170.0000 | American | Apr 17, 2020 |
| Put Options | Purchased | -2,400 | 160.0000 | American | Jan 15, 2021 |
| Call Options | Purchased | 600 | 150.0000 | American | Jan 15, 2021 |
| Put Options | Written | 3,700 | 215.0000 | American | Jan 15, 2021 |
| Put Options | Purchased | -7,200 | 180.0000 | American | Jan 15, 2021 |
| Put Options | Purchased | -800 | 185.0000 | American | May 15, 2020 |
| Call Options | Purchased | 9,200 | 195.0000 | American | Jan 15, 2021 |
| Put Options | Written | 23,900 | 160.0000 | American | Apr 17, 2020 |
| Put Options | Written | 3,900 | 175.0000 | American | Aug 21, 2020 |
| Put Options | Written | 4,500 | 195.0000 | American | Aug 21, 2020 |
| Put Options | Purchased | -4,000 | 145.0000 | American | May 15, 2020 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200420005493/en/
Copyright Business Wire 2020